2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SHARPE, C. C. Articles by HENDRY, B. M. Search for Related Content PubMed PubMed Citation Articles by SHARPE, C. C. Articles by HENDRY, B. M.

Role of Ras Isoforms in the Stimulated Proliferation of Human Renal Fibroblasts in Primary Culture

CLAIRE C. SHARPE^*, MARK E. C. DOCKRELL^*, MAZHAR I. NOOR^*, BRETT P. MONIA and BRUCE M. HENDRY^*

^* Cell Signalling Group, Department of Renal Medicine, Guy's, King's College and St. Thomas' School of Medicine, King's College London, London, United Kingdom
Department of Molecular Pharmacology, ISIS Pharmaceuticals, Carlsbad, California.

Correspondence to Dr. Bruce M. Hendry, Department of Renal Medicine, King's College London, Bessemer Road, London SE5 9PJ, United Kingdom. Phone: 44-171-346-3741; Fax: 44-171-346-3742; E-mail: bruce.hendry{at}kcl.ac.uk

Abstract. The proliferation of renal fibroblasts is implicated in the pathophysiologic processes of renal fibrosis. Many of the growth factors involved in proliferation are known to activate intracellular signaling pathways that converge on Ras monomeric GTPases. Although three ras family genes exist, their functional specificity is not yet known. Using antisense oligonucleotides, a role for Kirsten (Ki)-Ras in the stimulated proliferation of a primate renal fibroblast cell line was previously demonstrated. This study examines Ras in primary cultures of adult human renal fibroblasts. Using reverse transcription-PCR, mRNA for Harvey (Ha)-ras, Ki(4B)-ras, and neural (N)-ras, but not Ki(4A)-ras, were detected. Antisense oligonucleotides targeting Ha-, Ki-, and N-ras mRNA, which were used for liposomal transfection at 100 to 200 nM, were demonstrated to be active and isoform-specific in quantitative reverse transcription-PCR assays. Cellular Ras protein levels, as estimated using isoform-specific monoclonal antibodies, indicated that Ki-Ras was the predominantly expressed isoform (>95% of total Ras protein) under both serum-containing and serum-free conditions, with N- and Ha-Ras being detected in small amounts. Consistent with this finding, the antisense oligonucleotide directed against Ki-Ras reduced total cellular Ras levels by >70%, whereas Ha-Ras, N-Ras, and control oligonucleotides had no significant effect. Proliferation of oligonucleotide-transfected cells was measured using epidermal growth factor (EGF) and serum stimulation. The Ki-Ras oligonucleotide at 100 nM reduced serum-stimulated proliferation by >50% and EGF-stimulated proliferation by 25%, compared with data obtained with the control oligonucleotide (P < 0.01). The N-Ras oligonucleotide was not active, compared with the control oligonucleotide. The Ha-Ras oligonucleotide was not significantly active at 100 nM but reduced serum-stimulated proliferation by 13% and EGF-stimulated growth by 40% at 200 nM (P < 0.01). These results demonstrate that Ki-Ras(4B) is the predominantly expressed Ras isoform in human renal fibroblasts in primary culture and is important for both serum- and EGF-stimulated proliferation. Ha-Ras appears to be expressed at low levels but may also play a distinct role in stimulated proliferation.

This article has been cited by other articles:

				J.-H. Wang, B. M. Hendry, and C. C. Sharpe Silencing genes in the kidney: antisense or RNA interference? Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2115 - 2118. [Full Text] [PDF]

				H. M. Kocher, R. Senkus, M. Al-Nawab, and B. M. Hendry Subcellular distribution of Ras GTPase isoforms in normal human kidney Nephrol. Dial. Transplant., May 1, 2005; 20(5): 886 - 891. [Abstract] [Full Text] [PDF]

				A. Singh, A. P. Sowjanya, and G. Ramakrishna The wild-type Ras: road ahead FASEB J, February 1, 2005; 19(2): 161 - 169. [Abstract] [Full Text] [PDF]

				J. M. Williams and C. O. S. Savage Characterization of the Regulation and Functional Consequences of p21ras Activation in Neutrophils by Antineutrophil Cytoplasm Antibodies J. Am. Soc. Nephrol., January 1, 2005; 16(1): 90 - 96. [Abstract] [Full Text] [PDF]

				S. Yamashita, A. Maeshima, I. Kojima, and Y. Nojima Activin A Is a Potent Activator of Renal Interstitial Fibroblasts J. Am. Soc. Nephrol., January 1, 2004; 15(1): 91 - 101. [Abstract] [Full Text] [PDF]

				H. M. Kocher, J. Moorhead, C. C. Sharpe, M. E. C. Dockrell, M. Al-Nawab, and B. M. Hendry Expression of Ras GTPases in normal kidney and in glomerulonephritis Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2284 - 2292. [Abstract] [Full Text] [PDF]

				I. Perez de Castro, R. Diaz, M. Malumbres, M.-I. Hernandez, J. Jagirdar, M. Jimenez, D. Ahn, and A. Pellicer Mice Deficient for N-ras: Impaired Antiviral Immune Response and T-Cell Function Cancer Res., April 1, 2003; 63(7): 1615 - 1622. [Abstract] [Full Text] [PDF]

				H. C. Clarke, H. M. Kocher, A. Khwaja, Y. Kloog, H. T. Cook, and B. M. Hendry Ras Antagonist Farnesylthiosalicylic Acid (FTS) Reduces Glomerular Cellular Proliferation and Macrophage Number in Rat Thy-1 Nephritis J. Am. Soc. Nephrol., April 1, 2003; 14(4): 848 - 854. [Abstract] [Full Text] [PDF]

				C. C. Sharpe and B. M. Hendry Signaling: Focus on Rho in Renal Disease J. Am. Soc. Nephrol., January 1, 2003; 14(1): 261 - 264. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673